Frank Weinz: Arjo is Focussing on Strategies for Preventing DVT and PE
Frank Weinz, DVT Spezialist at Arjo, reposted from RPTH Journal on LinkedIn:
”Very important information about the risks for getting thrombosis, developing from orthopedic surgeries.
Arjo is focussing on strategies for preventing DVT and PE.
With the Flowtron ACS900, HCW‘s are having an effective and evidence prooved device for DVT prevention.”
Quoting RPTH Journal‘s post:
”We often assume VTE risk after major orthopedic surgery quickly returns to baseline.
This commentary from Charlotte Story, Lauren Merz and Jordan Schaefer takes a closer look at longer-term risk, current definitions, and what they may miss when we focus only on the early postoperative period.”
Read the full review in RPTH.
Article: Rethinking venous thromboembolism risk after major orthopedic surgery: a transient threat or a persistent problem?
Authors: Charlotte Story, Lauren E. Merz, Jordan K. Schaefer
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 25, 2026, 16:47Alan Nurden: Platelet Defects Explain Bleeding in EHDS Patients
-
Feb 25, 2026, 16:40Mohammed Almohammadi: Uniting Leaders in Laboratory Hematology at the 1st Saudi ISLH Joint Conference
-
Feb 25, 2026, 16:37Salihu Asimawu: Inflammation Is Not a Disease – Hats Off to the Heroes Inside Us
-
Feb 25, 2026, 16:34Michael Makris: Biomarin Has Decided to Withdraw Roctavian from the Market
-
Feb 25, 2026, 16:25Tagreed Alkaltham: The Blood Banker Personality
-
Feb 25, 2026, 16:17Sanjay Ahuja: Insightful Talk on 100 Years of VWD by Jorge Di Paola
-
Feb 25, 2026, 15:20Michael Shapiro։ Creating Real Pathways for Trainees in Preventive Cardiology
-
Feb 25, 2026, 15:15Ajay Kumar: Plasma Component Quality Control Standards
-
Feb 25, 2026, 15:09Wolfgang Miesbach: Efficacy, Safety and Thrombosis Signals in Haemophilia A/B with Inhibitors